• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 1 Device Recall Nova Max Glucose Test Strips

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards | Inspections
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 1 Recall
Nova Max Glucose Test Strips
see related information
Date Posted August 09, 2013
Recall Status1 Open
Recall Number Z-1897-2013
Recall Event ID 65617
Premarket Notification
510(K) Number
K091547 
Product Classification System, Test, Blood Glucose, Over The Counter - Product Code NBW
Product Nova Max Glucose Test Strips (50 Count Retail) Catalog Number: 43437 Product Usage: The Nova Max Glucose Test Strips are for use with the Nova Max Family of Glucose Monitors (Nova Max, Nova Max Plus, Nova Max Link, BD Logic and Paradigm Link). These monitors are intended to be used for the quantitative measurement of glucose in fresh capillary whole blood. They are intended for use by people with diabetes mellitus in the home and by healthcare professionals in clinical settings as an aid to monitor the effectiveness of diabetes control
Code Information Lot #/Exp.Date: 1010211346 12/31/2013 1020212032 02/28/2014 1020212100 04/30/2014 1020212101 04/30/2014 1020212153 06/30/2014 1020212207 07/31/2014 1020212291 10/31/2014 1020213074 03/31/2015 1020213109 04/30/2015 1020411347 12/31/2013 1020412255 09/30/2014 1020412341 12/31/2014 1020512087 03/31/2014 1020611348 12/31/2013 1020712206 07/31/2014 1020811350 12/31/2013
Recalling Firm/
Manufacturer
Nova Biomedical Corporation
200 Prospect St
Waltham, Massachusetts 02453
Manufacturer Reason
for Recall
Reports of false abnormally high glucose readings from test strips
FDA Determined
Cause 2
COMPONENT CONTROLS (GMP - GOOD MANUFACTURING PRACTICE): Material/Component Contamination
Action Nova Biomedical U.S.A issued an Urgent Medical Device Voluntary Recall Letter dated July 19, 2013 via registered/certified letters to affected customers. The letter identified the affected product, problem and actions to be taken. Customers were instructed to immediately discontinue use of the affected product; contact Nova Diabetes Care Customer Service for replacement strips; do not stop testing blood glucose while waiting for replacement strips; if affected strips must be used follow precautions provided in notification letter. For questions call Nova Diabetes Care Customer Service at 1-800-681-7390. .
Quantity in Commerce 22,395,802 test strips
Distribution Worldwide Distribution - USA Nationwide and the countries of Chile, England , Peru, Nicaragua
Total Product Life Cycle TPLC Device Report

 
1 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
510(K) Database 510(K)s with Product Code = NBW and Original Applicant = NOVA BIOMEDICAL CORP.
-
-